Prostate Cancer Connect
  • Saved


Prostate adenocarcinoma with mucinous features - is it PSMA avid? - PubMed

Prostate adenocarcinoma with mucinous features - is it PSMA avid? - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34524723/

doi: 10.1111/1754-9485.13327. Online ahead of print. 1 Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia. 2 Department of Nuclear Medicine and Theranostics, St. Vincent's...

  • Saved


Hard Times: Prostate Cancer Patients' Experiences with Erectile Aids - PubMed

Hard Times: Prostate Cancer Patients' Experiences with Erectile Aids - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34526246/

This paper illustrates several challenges to EA use, while providing insight into reasons for abandonment of use of EAs. Walker LM, Sears CS, Santos-Iglesias P, et al. Hard Times: Prostate...

  • Saved


Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation - PubMed

Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34522795/

Together, this global collaborative review on the postoperative management of prostate cancer suggested a stronger signal for the uptake of early salvage radiation treatment with careful PSA monitoring, more sensitive...

  • Saved

Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate - PubMed

Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34505227/

doi: 10.1007/s11255-021-02989-2. Online ahead of print. 1 Department of Urology and Andrology, Klinikum Klagenfurt, Feschnigstrasse 11, 9020, Klagenfurt, Austria. [email protected]. 2 Department of Pharmacology, Zagreb University School of Medicine, Zagreb,...

  • Saved

Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer - PubMed

Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34506104/

All current clinically approved androgen deprivation therapies for prostate cancer target the C-terminal ligand-binding domain of the androgen receptor (AR). However, the main transactivation function of the receptor is localized...